Skip Nav Destination
Abstract A082: Developing a PD-1 based inhibitory chimeric antigen receptor (ICAR) for co-expression, to overcome off-tumor toxicity when targeting ErbB2 using engineered T cells
Cancer Immunol Res (2016) 4 (1_Supplement): A082.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Xianqiang Liu
- Nan Zhang
- Huan Shi
Oncotarget (2017) 8 (37): 62730.
Realism and pragmatism in developing an effective chimeric antigen receptor T-cell product for solid cancers
- Ahmed Z. Gad
- Shahenda El-Naggar
- Nabil Ahmed
Cytotherapy (2016) 18 (11): 1382.